Viatris (VTRS) Amortization of Goodwill (2023 - 2025)
Viatris' (VTRS) quarterly Amortization of Goodwill came in at $2.9 billion in Q1 2025, up 814.89% quarter-over-quarter from $321.0 million in Q2 2024.
Viatris (VTRS) Amortization of Goodwill (2023 - 2025) Analysis & Trends
Viatris' Amortization of Goodwill history runs 3 years deep, the most recent figure standing at $2.9 billion for Q1 2025.
- On a quarterly basis, Amortization of Goodwill changed N/A year-over-year to $2.9 billion in Q1 2025; TTM through Dec 2025 was $2.9 billion, a 814.89% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 814.89% from the prior year.
- Amortization of Goodwill grew to $2.9 billion in Q1 2025 per VTRS's latest filing, from $321.0 million in the prior quarter.
- Across five years, Amortization of Goodwill topped out at $2.9 billion in Q1 2025 and bottomed at $321.0 million in Q2 2024.
- The 3-year median for Amortization of Goodwill is $580.1 million (2023), against an average of $1.3 billion.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.94 Bn |
| Mar 31, 2025 | 2.94 Bn |
| Jun 30, 2024 | 321.00 Mn |
| Jun 30, 2024 | 321.00 Mn |
| Dec 31, 2023 | 580.10 Mn |
| Dec 31, 2023 | 580.10 Mn |